Coronary embolism following aortic and mitral valve replacement: Successful management with abciximab and urokinase
Authors:
- 1 April 1998
- journal article
- case report
- Published by Wiley in Catheterization and Cardiovascular Diagnosis
- Vol. 43 (4) , 457-459
Abstract
We report a case of coronary embolism in a 63‐year‐old woman with St. Jude aortic and mitral valve replacements who presented with acute myocardial infarction. Urgent catheterization revealed a saddle embolus in the proximal part of the circumflex and ramus arteries and another embolus in a diagonal branch. After employing angioplasty for the totally occluding diagonal embolus, a combined regimen of intracoronary urokinase and intravenous abciximab was successful in achieving complete resolution of the emboli. Cathet. Cardiovasc. Diagn. 43:457–459, 1998.Keywords
This publication has 7 references indexed in Scilit:
- Thromboembolic risk and late survival after mitral valve replacement with the St. Jude Medical valveThe Annals of Thoracic Surgery, 1994
- Embolizing Fibroelastoma of the Aortic ValveCardiovascular Surgery, 1994
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- Amyloid, thrombosis, and acute myocardial infarction in association with a bicuspid aortic valve.Heart, 1993
- Coronary embolization after balloon angioplasty or thromolytic therapy: An autopsy study of 32 casesJACC, 1993
- Prolonged infusion of urokinase for recanalization of chronically occluded aortocoronary bypass graftsThe American Journal of Cardiology, 1988
- Diagnosis of Coronary Embolism: A Review1Journal of the Royal Society of Medicine, 1983